India's drug regulator DCGI on Wednesday granted approval to Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to news agency ANI.
from Zee News :India National https://ift.tt/3EV9owu
Wednesday, January 5, 2022